Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data
dc.contributor.author | Williams, Randi M. | |
dc.contributor.author | Li, Tengfei | |
dc.contributor.author | Luta, George | |
dc.contributor.author | Wang, Min Qi | |
dc.contributor.author | Adams-Campbell, Lucile | |
dc.contributor.author | Meza, Rafael | |
dc.contributor.author | Tammemägi, Martin C. | |
dc.contributor.author | Taylor, Kathryn L. | |
dc.date.accessioned | 2022-05-06T17:25:22Z | |
dc.date.available | 2023-06-06 13:25:21 | en |
dc.date.available | 2022-05-06T17:25:22Z | |
dc.date.issued | 2022-05-01 | |
dc.identifier.citation | Williams, Randi M.; Li, Tengfei; Luta, George; Wang, Min Qi; Adams-Campbell, Lucile ; Meza, Rafael; Tammemägi, Martin C. ; Taylor, Kathryn L. (2022). "Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data." Cancer (9): 1812-1819. | |
dc.identifier.issn | 0008-543X | |
dc.identifier.issn | 1097-0142 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/172243 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Centers for Disease Control and Prevention | |
dc.subject.other | lung cancer screening | |
dc.subject.other | US Preventive Services Task Force | |
dc.subject.other | race disparities | |
dc.subject.other | Behavioral Risk Factor Surveillance System | |
dc.subject.other | low dose computed tomography | |
dc.subject.other | PLCOm2012 risk prediction model | |
dc.title | Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172243/1/cncr34098.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172243/2/cncr34098_am.pdf | |
dc.identifier.doi | 10.1002/cncr.34098 | |
dc.identifier.source | Cancer | |
dc.identifier.citedreference | Darling GE, Tammemägi MC, Schmidt H, et al. Organized lung cancer screening pilot: informing a province-wide program in Ontario, Canada. Ann Thorac Surg. 2021; 111: 1805 - 1811. doi: 10.1016/j.athoracsur.2020.07.051 | |
dc.identifier.citedreference | Pasquinelli MM, Kovitz KL, Koshy M, et al. Outcomes from a minority-based lung cancer screening program vs the National Lung Screening Trial. JAMA Oncol. 2018; 4: 1291. doi: 10.1001/jamaoncol.2018.2823 | |
dc.identifier.citedreference | Annangi S, Nutalapati S, Foreman MG, Pillai R, Flenaugh EL. Potential racial disparities using current lung cancer screening guidelines. J Racial Ethn Health Disparities. 2019; 6: 22 - 26. doi: 10.1007/s40615-018-0492-z | |
dc.identifier.citedreference | CDCTobaccoFree. Burden of tobacco use in the U.S. Centers for Disease Control and Prevention. Published April 23, 2018. Accessed May 14, 2018. https://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html | |
dc.identifier.citedreference | Han SS, Chow E, ten Haaf K, et al. Disparities of national lung cancer screening guidelines in the U.S. population. J Natl Cancer Inst. 2020; 112: 1136 - 1142. doi: 10.1093/jnci/djaa013 | |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence—38 states and the District of Columbia, 1998-2006. MMWR Morb Mortal Wkly Rep. 2010; 59: 1434 - 1438. | |
dc.identifier.citedreference | de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020; 382: 503 - 513. doi: 10.1056/NEJMoa1911793 | |
dc.identifier.citedreference | Landy R, Young CD, Skarzynski M, et al. Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines. J Natl Cancer Inst. 2021; 113: 1590 - 1594. doi: 10.1093/jnci/djaa211 | |
dc.identifier.citedreference | Henderson LM, Rivera MP, Basch E. Broadened eligibility for lung cancer screening: challenges and uncertainty for implementation and equity. JAMA. 2021; 325: 939 - 941. doi: 10.1001/jama.2020.26422 | |
dc.identifier.citedreference | Ryan BM. Lung cancer health disparities. Carcinogenesis. 2018; 39: 741 - 751. doi: 10.1093/carcin/bgy047 | |
dc.identifier.citedreference | Haiman CA, Stram DO, Wilkens LR, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354: 333 - 342. doi: 10.1056/NEJMoa033250 | |
dc.identifier.citedreference | Pasquinelli MM, Tammemagi MC, Kovitz KL, et al. Risk prediction model versus United States Preventive Services Task Force lung cancer screening eligibility criteria: reducing race disparities. J Thorac Oncol. 2020; 15: 1738 - 1747. doi: 10.1016/j.jtho.2020.08.006 | |
dc.identifier.citedreference | Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013; 368: 728 - 736. doi: 10.1056/NEJMoa1211776 | |
dc.identifier.citedreference | Fiscella K, Winters P, Farah S, Sanders M, Mohile SG. Do lung cancer eligibility criteria align with risk among Blacks and Hispanics? PLoS One. 2015; 10: e0143789. doi: 10.1371/journal.pone.0143789 | |
dc.identifier.citedreference | ten Haaf K, Jeon J, Tammemägi MC, et al. Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study. PLoS Med. 2017; 14: e1002277. doi: 10.1371/journal.pmed.1002277 | |
dc.identifier.citedreference | Katki HA, Kovalchik SA, Petito LC, et al. Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening. Ann Intern Med. 2018; 169: 10. doi: 10.7326/M17-2701 | |
dc.identifier.citedreference | National Health Service England. Targeted screening for lung cancer with low radiation dose computed tomography. Accessed September 20, 2021. https://www.england.nhs.uk/publication/targeted-screening-for-lung-cancer/ | |
dc.identifier.citedreference | Pasquinelli MM, Tammemägi MC, Kovitz KL, et al. Addressing sex disparities in lung cancer screening eligibility: USPSTF vs PLCOm2012 criteria. Chest. 2021;Jul 9:S0012-3692(21)01316-70(0). doi: 10.1016/j.chest.2021.06.066 | |
dc.identifier.citedreference | Tammemägi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014; 11: e1001764. doi: 10.1371/journal.pmed.1001764 | |
dc.identifier.citedreference | Meza R, Jeon J, Toumazis I, et al. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force. JAMA. 2021; 325: 988. doi: 10.1001/jama.2021.1077 | |
dc.identifier.citedreference | Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991; 10: 585 - 598. doi: 10.1002/sim.4780100410 | |
dc.identifier.citedreference | Reese TJ, Schlechter CR, Potter LN, et al. Evaluation of revised US Preventive Services Task Force lung cancer screening guideline among women and racial/ethnic minority populations. JAMA Netw Open. 2021; 4: e2033769. doi: 10.1001/jamanetworkopen.2020.33769 | |
dc.identifier.citedreference | Holford TR, Levy DT, Meza R. Comparison of smoking history patterns among African American and White cohorts in the United States born 1890 to 1990. Nicotine Tob Res. 2016; 18 ( suppl 1 ): S16 - S29. doi: 10.1093/ntr/ntv274 | |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Hispanics/Latinos and tobacco use. Published December 17, 2018. Accessed September 20, 2021. https://www.cdc.gov/tobacco/disparities/hispanics-latinos/index.htm | |
dc.identifier.citedreference | Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996; 18: 188 - 204. doi: 10.1093/oxfordjournals.epirev.a017925 | |
dc.identifier.citedreference | US Census Bureau QuickFacts: United States. Accessed September 20, 2021. https://www.census.gov/quickfacts/fact/table/US/PST045219 | |
dc.identifier.citedreference | Fedewa SA, Kazerooni EA, Studts JL, et al. State variation in low-dose computed tomography scanning for lung cancer screening in the United States. J Natl Cancer Inst. 2021; 113: 1044 - 1052. doi: 10.1093/jnci/djaa170 | |
dc.identifier.citedreference | Fedewa SA, Bandi P, Smith RA, Silvestri GA, Jemal A. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2021;July 21:S0012-3692(21)01364-7. doi: 10.1016/j.chest.2021.07.030 | |
dc.identifier.citedreference | Maki KG, Shete S, Volk RJ. Examining lung cancer screening utilization with public-use data: opportunities and challenges. Prev Med. 2021; 147: 106503. doi: 10.1016/j.ypmed.2021.106503 | |
dc.identifier.citedreference | American Lung Association. Healthcare & lung disease initiatives. Accessed July 9, 2021. https://www.lung.org/policy-advocacy/healthcare-lung-disease/lung-cancer-policy/toolkit | |
dc.identifier.citedreference | American Cancer Society Cancer facts & figures for African Americans 2016-2018. Published online 2016. Accessed November 12, 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2016-2018.pdf | |
dc.identifier.citedreference | Zahnd WE, Eberth JM. Lung cancer screening utilization: a Behavioral Risk Factor Surveillance System analysis. Am J Prev Med. 2019; 57: 250 - 255. doi: 10.1016/j.amepre.2019.03.015 | |
dc.identifier.citedreference | Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015. JAMA Oncol. 2017; 3: 1278 - 1281. doi: 10.1001/jamaoncol.2016.6416 | |
dc.identifier.citedreference | Aberle DR. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395 - 409. doi: 10.1056/NEJMoa1102873 | |
dc.identifier.citedreference | Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160: 330 - 338. doi: 10.7326/M13-2771 | |
dc.identifier.citedreference | Advani S, Zhang D, Tammemagi M, et al. Comorbidity profiles and lung cancer screening among older adults: U.S. Behavioral Risk Factor Surveillance System 2017 to 2019. Ann Am Thorac Soc. 2021; 18: 1886 - 1893. doi: 10.1513/AnnalsATS.202010-1276OC | |
dc.identifier.citedreference | Kee D, Wisnivesky J, Kale MS. Lung cancer screening uptake: analysis of BRFSS 2018. J Gen Intern Med. 2021; 36: 2897 - 2899. doi: 10.1007/s11606-020-06236-9 | |
dc.identifier.citedreference | Narayan AK, Gupta Y, Little BP, Shepard JO, Flores EJ. Lung cancer screening eligibility and use with low-dose computed tomography: results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey. Cancer. 2021; 127: 748 - 756. doi: 10.1002/cncr.33322 | |
dc.identifier.citedreference | Richards TB. Screening for lung cancer—10 states, 2017. MMWR Morb Mortal Wkly Rep. 2020; 69: 201 - 206. doi: 10.15585/mmwr.mm6908a1 | |
dc.identifier.citedreference | Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol. 2019; 5: 1318. doi: 10.1001/jamaoncol.2019.1402 | |
dc.identifier.citedreference | Pinsky PF, Kramer BS. Lung cancer risk and demographic characteristics of current 20-29 pack-year smokers: implications for screening. J Natl Cancer Inst. 2015; 107: djv226. doi: 10.1093/jnci/djv226 | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.